Nanomedicine is essentially based on the medical application of nanotechnology in diagnosing, treating and/or prevention of diseases and infections. Nanotechnology-based drugs and treatments are applied for treating cardiovascular, neurological, and oncology diseases.
Orphan drugs market Report with Leading Competitor Analysis, Strategies and F...IMARC Group
The global orphan drugs market exhibited moderate growth during 2014-2019. Looking forward, IMARC Group expects the global orphan drugs market to exhibit moderate growth during the next five years.
To learn more about this market, visit us at: https://www.imarcgroup.com/orphan-drugs-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The report provides an analysis of the key trends in each sub-segment of the global orphan drugs market report, along with forecasts for growth at the global, regional and country level from 2020-2025. The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players.
For more information, request for a free sample report here: https://www.imarcgroup.com/orphan-drugs-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Immuno-oncology, also called as cancer immunotherapy is a biologic treatment, which enhances the body’s natural defenses to stop the growth of cancer. This therapy uses constituents made by the body or in a research laboratory to improve or reestablish the immune system function.
Global in vitro diagnostics (ivd) market (technique, product, usability, appl...Allied Market Research
"In Vitro Diagnostics Market (Techniques, Product Type, Usability, Applications, End-Users, Geography) - Industry Analysis, Trends, Share, Opportunities and Forecast, 2013 - 2020," the global In Vitro Diagnostics market has a potential to reach $74.46 billion by 2020 with North America being the largest regional market. North America is forecast to reach $30.1 billion by 2020 growing at a CAGR of 4.02% during 2014-2020. Asia-Pacific is forecast to be the fastest growing market and is expected to grow at a CAGR of 7.49% during the forecast period (from 2014 to 2020).
Blood culture test market Research, Industry Trends, Strategies, Growth, Regi...IMARC Group
According to IMARC Group, the global Blood Culture Test market is expected to experience strong growth during the forecast period (2020-2025).
To learn more about this market, visit us at: https://www.imarcgroup.com/blood-culture-test-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
A rise in the incidences of bloodstream infections (BSI), sepsis, and environment borne diseases around the world have majorly contributed to the growth of the market. Apart from this, the increasing cases of bacterial infections like tuberculosis (TB) in developing and underdeveloped countries are fueling the demand for bacterial culture tests.
For more information, request for a free sample report here: https://www.imarcgroup.com/blood-culture-test-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Orphan drugs market Report with Leading Competitor Analysis, Strategies and F...IMARC Group
The global orphan drugs market exhibited moderate growth during 2014-2019. Looking forward, IMARC Group expects the global orphan drugs market to exhibit moderate growth during the next five years.
To learn more about this market, visit us at: https://www.imarcgroup.com/orphan-drugs-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The report provides an analysis of the key trends in each sub-segment of the global orphan drugs market report, along with forecasts for growth at the global, regional and country level from 2020-2025. The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players.
For more information, request for a free sample report here: https://www.imarcgroup.com/orphan-drugs-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Immuno-oncology, also called as cancer immunotherapy is a biologic treatment, which enhances the body’s natural defenses to stop the growth of cancer. This therapy uses constituents made by the body or in a research laboratory to improve or reestablish the immune system function.
Global in vitro diagnostics (ivd) market (technique, product, usability, appl...Allied Market Research
"In Vitro Diagnostics Market (Techniques, Product Type, Usability, Applications, End-Users, Geography) - Industry Analysis, Trends, Share, Opportunities and Forecast, 2013 - 2020," the global In Vitro Diagnostics market has a potential to reach $74.46 billion by 2020 with North America being the largest regional market. North America is forecast to reach $30.1 billion by 2020 growing at a CAGR of 4.02% during 2014-2020. Asia-Pacific is forecast to be the fastest growing market and is expected to grow at a CAGR of 7.49% during the forecast period (from 2014 to 2020).
Blood culture test market Research, Industry Trends, Strategies, Growth, Regi...IMARC Group
According to IMARC Group, the global Blood Culture Test market is expected to experience strong growth during the forecast period (2020-2025).
To learn more about this market, visit us at: https://www.imarcgroup.com/blood-culture-test-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
A rise in the incidences of bloodstream infections (BSI), sepsis, and environment borne diseases around the world have majorly contributed to the growth of the market. Apart from this, the increasing cases of bacterial infections like tuberculosis (TB) in developing and underdeveloped countries are fueling the demand for bacterial culture tests.
For more information, request for a free sample report here: https://www.imarcgroup.com/blood-culture-test-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Therapeutic Nuclear Medicines Market Worth Observing Growth Top Key Player- B...Market Media Hub
In the past few years, more efficient therapeutic nuclear medicines have been launched, which have shown positive results for the treatment of various types of cancer. For instance, the launch of Xofigo (Radium-223) by Bayer for the treatment of prostate cancer and the launch of Lutathera (Lutetium-177) for the treatment of neuroblastoma and synovitis has created growth opportunities for the therapeutic nuclear medicines market over the forecast period.
Cancer immunotherapies from the perspectives of oncology nursesZeena Nackerdien
This presentation, tailored for oncology nurses, provides an overview of immunotherapy classes, how they work, and how key side effects are typically managed. (Disclaimer: Content is based on peer-reviewed literature; however, it is not a substitute for medical advice. Please consult your doctor)
A recent report published by Infinium Global Research on chromatography instruments market provides in depth analysis of segments and sub-segments in global as well as regional markets of chromatography instruments market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional markets of chromatography instruments over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global chromatography instruments market. According to report the global chromatography instruments market is projected to grow at a CAGR of 7.0% over the forecast period of 2017 - 2023. The global market size was USD 6.89 billion in 2015.
Gynecological Devices Market Size, Share and Trend Analysis ReportSignitech
The global gynecological devices market size was valued at USD 8.9 billion in 2018. It is anticipated to exhibit a CAGR of 8.4% during the forecast period.
Molecular cytogenetics market Report, Industry Analysis, Share, Size and Fore...IMARC Group
According to IMARC Group, the global molecular cytogenetics market is expected to continue its strong growth during the next five years.
To learn more about this market, visit us at: https://www.imarcgroup.com/molecular-cytogenetics-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The report provides an analysis of the key trends in each sub-segment of the global molecular cytogenetics market report, along with forecasts for growth at the global, regional and country level from 2020-2025. The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players.
For more information, request for a free sample report here: https://www.imarcgroup.com/molecular-cytogenetics-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Electronic prescribing or E-Prescribing (e-Rx) is electronic transmission of prescriptions from physician to pharmacists using computer and other mobile devices, such as cell phone and tablets. E-Prescribing system has replaced the phone, paper and fax based method of prescription. The system improves patient safety by reducing prescribing errors due to various reasons, such as illegible handwriting and ambiguous abbreviations. It also reduces healthcare costs over the paper based prescription systems. It permits the physician and other healthcare professionals to regenerate a new prescription, when any prescription error occurs during pharmacy operation.
The total U.S. food safety testing market is valued at $3.4 billion in 2010 and is projected to increase at a 6.6% compound annual growth rate (CAGR) over the next
Global leukapheresis market size, trends & analysis forecasts to 2026SandeepVishwakarma82
Leukapheresis Market: Insights
The global Leukapheresis market is estimated to witness a significant CAGR during the forecast period (2020-2026). Increasing incidence and prevalence of leukemia is one of the major factor expected to propel the market growth for leukapheresis during the forecast period. According to NIH estimates, the number of new cases of leukemia has increased on an average rate of 0.3% each year over the last 10 years. They also estimated that in 2018 approximately 60,300 cases were registered.
Request a free sample copy of the report @https://www.globalmarketestimates.com/market-report/global-leukapheresis-market-2060
The North American market is the biggest IVD market, globally and also the biggest consumption market. The San Francisco Bay Area may be often considered as a natural home to well established IVD device leaders responsible for spearheading industry advancements including Bio-Rad, Roche and Thermo Fisher and many other promising startups breaking into the market. Currently it has approximately 30% share of the global market and would exceed the share by 2020, growing at a CAGR of 3.57% from 2019 till 2025.
Global regenerative medicines market (technology, application and geography) ...Allied Market Research
Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process.
Global regenerative medicines market (technology, application and geography) ...Debbie Shields
Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process.
Intracranial Abscess Treatment Market: Covid-19 Impact Analysis, Supply Demand Scenario and Growth Prospects Survey till 2030 investigated in the latest research
Therapeutic Nuclear Medicines Market Worth Observing Growth Top Key Player- B...Market Media Hub
In the past few years, more efficient therapeutic nuclear medicines have been launched, which have shown positive results for the treatment of various types of cancer. For instance, the launch of Xofigo (Radium-223) by Bayer for the treatment of prostate cancer and the launch of Lutathera (Lutetium-177) for the treatment of neuroblastoma and synovitis has created growth opportunities for the therapeutic nuclear medicines market over the forecast period.
Cancer immunotherapies from the perspectives of oncology nursesZeena Nackerdien
This presentation, tailored for oncology nurses, provides an overview of immunotherapy classes, how they work, and how key side effects are typically managed. (Disclaimer: Content is based on peer-reviewed literature; however, it is not a substitute for medical advice. Please consult your doctor)
A recent report published by Infinium Global Research on chromatography instruments market provides in depth analysis of segments and sub-segments in global as well as regional markets of chromatography instruments market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional markets of chromatography instruments over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global chromatography instruments market. According to report the global chromatography instruments market is projected to grow at a CAGR of 7.0% over the forecast period of 2017 - 2023. The global market size was USD 6.89 billion in 2015.
Gynecological Devices Market Size, Share and Trend Analysis ReportSignitech
The global gynecological devices market size was valued at USD 8.9 billion in 2018. It is anticipated to exhibit a CAGR of 8.4% during the forecast period.
Molecular cytogenetics market Report, Industry Analysis, Share, Size and Fore...IMARC Group
According to IMARC Group, the global molecular cytogenetics market is expected to continue its strong growth during the next five years.
To learn more about this market, visit us at: https://www.imarcgroup.com/molecular-cytogenetics-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The report provides an analysis of the key trends in each sub-segment of the global molecular cytogenetics market report, along with forecasts for growth at the global, regional and country level from 2020-2025. The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players.
For more information, request for a free sample report here: https://www.imarcgroup.com/molecular-cytogenetics-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Electronic prescribing or E-Prescribing (e-Rx) is electronic transmission of prescriptions from physician to pharmacists using computer and other mobile devices, such as cell phone and tablets. E-Prescribing system has replaced the phone, paper and fax based method of prescription. The system improves patient safety by reducing prescribing errors due to various reasons, such as illegible handwriting and ambiguous abbreviations. It also reduces healthcare costs over the paper based prescription systems. It permits the physician and other healthcare professionals to regenerate a new prescription, when any prescription error occurs during pharmacy operation.
The total U.S. food safety testing market is valued at $3.4 billion in 2010 and is projected to increase at a 6.6% compound annual growth rate (CAGR) over the next
Global leukapheresis market size, trends & analysis forecasts to 2026SandeepVishwakarma82
Leukapheresis Market: Insights
The global Leukapheresis market is estimated to witness a significant CAGR during the forecast period (2020-2026). Increasing incidence and prevalence of leukemia is one of the major factor expected to propel the market growth for leukapheresis during the forecast period. According to NIH estimates, the number of new cases of leukemia has increased on an average rate of 0.3% each year over the last 10 years. They also estimated that in 2018 approximately 60,300 cases were registered.
Request a free sample copy of the report @https://www.globalmarketestimates.com/market-report/global-leukapheresis-market-2060
The North American market is the biggest IVD market, globally and also the biggest consumption market. The San Francisco Bay Area may be often considered as a natural home to well established IVD device leaders responsible for spearheading industry advancements including Bio-Rad, Roche and Thermo Fisher and many other promising startups breaking into the market. Currently it has approximately 30% share of the global market and would exceed the share by 2020, growing at a CAGR of 3.57% from 2019 till 2025.
Global regenerative medicines market (technology, application and geography) ...Allied Market Research
Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process.
Global regenerative medicines market (technology, application and geography) ...Debbie Shields
Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process.
Intracranial Abscess Treatment Market: Covid-19 Impact Analysis, Supply Demand Scenario and Growth Prospects Survey till 2030 investigated in the latest research
Minimally Invasive Surgery Market overview 2013 - 2019Richard Smith
The global minimally invasive surgery (MIS) market from three perspectives, namely, types of devices used in performing these surgeries, various types of surgeries performed and the major geographic markets. The global market for MIS has been segmented into three main categories of devices that include surgical devices, monitoring and visualization devices, and endoscopy devices. Surgical devices are further classified as ablation devices, electrosurgical devices, and medical robotic systems. Similarly, the monitoring and visualization devices market has also been segmented into MRI equipment, CT scanners, X-ray devices, ultrasound equipment and other (PET and SPECT scanners, and combination devices such as PET/CT, PET/MRI, SPECT/CT, and SPECT/MRI).
This report focuses on the Global M health market size Market trends, future forecasts, growth opportunities, key end-user industries, and market players. The objectives of the study are to present the key developments of the market across the globe.
Market Research Reports, Inc. has announced the addition of “Patient Monitoring Global Market – Forecast To 2020” research report to their offering. See more at- http://mrr.cm/4fQ
The global brain monitoring market generated revenue of US$ 5.5 billion in 2020 and is expected to reach US$ 7.5 billion by 2025 with a CAGR of 6.5% in the forecast period. Growing incidences of neurological disorders & brain injury, growing geriatric population, and increasing investment in the medical sector to provide advanced research & treatment are the key factors driving the growth of the global brain monitoring market.
Monoclonal Antibodies Market PPT: Growth, Outlook, Demand, Keyplayer Analysis...IMARC Group
The global monoclonal antibodies market size reached US$ 207.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 307.8 Billion by 2028, exhibiting a growth rate (CAGR) of 6.9% during 2023-2028.
More Info:- https://www.imarcgroup.com/monoclonal-antibodies-market
The global brain monitoring market generated revenue of US$ 5.5 billion in 2020 and is expected to reach US$ 7.5 billion by 2025 with a CAGR of 6.5% in the forecast period. Growing incidences of neurological disorders & brain injury, growing geriatric population, and increasing investment in the medical sector to provide advanced research & treatment are the key factors driving the growth of the global brain monitoring market.
MarketResearchReports.com has announced the addition of “Forecast of Global Clinical Trial Supplies Consumption Market Report 2023” research report to their offering. See more at- http://mrr.cm/wWQ
The global organ-on-a-chip market generated revenue of US$ 23.3 million in 2020 and is expected to reach US$ 116.7 million by 2025 with a CAGR of 38.0% in the forecast period. The organ-on-a-chip market report offers a comprehensive market analysis of the different segments and regions that lets readers make crucial business-related decisions with a wealth of information enclosed in this report. The research report offers both qualitative and quantitative information on the global organ-on-a-chip market. In qualitative terms, the organ-on-a-chip market report provides insights into numerous factors, such as market determinants, value chain analysis, emerging trends, growth opportunity analysis, porters five-force model analysis and macro-economic factors, segment analysis, regional analysis at a granular level. Similarly, in quantitative terms, the report provides historical and forecast market numbers of organ-on-a-chip in various segments such as by Offerings, type, application & end-user at global, regional, and country-level. Also, the report provides a detailed analysis of the market vendors and their product offerings. The report also covers details of the competitive market environment and includes information on the capabilities and competencies of market vendors.
“Next-Generation Sequencing (NGS) Global Market – Forecast To 2022”Vinay Shiva Prasad
Next Generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced . In the last five years, the sequencing cost has rapidly reduced and this is supposed to have a huge impact on the NGS market in the coming years.
Androgenetic alopecia (AGA) is a patterned hair loss occurring due to systemic androgen and genetic factors. It is the most common cause of hair loss in both genders. It is characterized by follicular miniaturization in a patterned hair loss occurring due to systemic androgen and genetic factors.
"Healthcare Analytics Market By Type, By Component, By Application, By End-User,
Geography and Forecast 2019 to 2024"
https://www.globalmarketstudies.com/product/healthcare-analytics-market-report/
Nanomedicine Market Size, Analysis, Industry Demand, Growth and Forecast To 2...mahadev mahimkar
The Global Nanomedicine Market Research Report 2016 give insights upon the world's major regional market conditions of the Nanomedicine industry which mainly focus upon the main regions which include continents like North America, Europe and Asia and the main countries i.e. United States, Germany, Japan and China.
The global market for respiratory care device is expected to grow from $ 21,765.7 million in 2021 to $ 33,183.2 million in 2026. The market is expected to grow at a CAGR of 8.8% over the forecast period (2021-2026). Some of the market's key participants are ACOMA, Apex Medical, BMC Medical, Breas Medical, CareFusion Corporation (BD), Chart Industries, Covidien(Medtronic), DeVilbiss Healthcare(Drive Medical), Dräger, Fisher and Paykel Healthcare, GF Health Products, Hamilton Medical, Heyer Medical, Inogen, Invacare, MGC Diagnostics Corporation, Maquet, Masimo Corporation, Nihon Kohden Corporation, Omron Healthcare, PARI Medical Holding GmbH, Philips Respironics, ResMed, SDI Diagnostics, Sysmed, Teleflex, Weinmann, Yuyue Medical. This report intends to identify significant growth areas and to explore relevant market strategies. This in-depth analysis delves into the global market for respiratory care device. The primary goal of this research is to examine the potential growth areas, significant trends, and the market's impact on the industry. The report also reviews the adoption of respiratory care device in both established and emerging markets.
Clinical trial is a medical research study performed on humans to check the safety and efficacy of drugs, devices and therapeutic products before they are finally launched in the market. Proper management of clinical trials has become a priority for hospitals, pharmaceutical companies and clinical research organizations (CRO).
Similar to Nanomedicine Market Size 2013-2019 (20)
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
Nanomedicine Market Size 2013-2019
1. Contact Us : State Tower,90 State Street,Suite 700,Albany NY – 12207,United States
Tel: +1-518-618-1030 Email: sales@transparencymarketresearch.com
Transparency Market Research (TMR) provides a range of marketing
and business research solutions designed for your specific needs. From
off-the-shelf syndicated business & market research to made-to-order
custom research, we serve our clients to fulfill their immediate as well
as ongoing research requirements.
2. Single User License US $ 4795
Multi User License US $ 7795
Corporate User License US $ 10795
Nanomedicine Market - Global
Industry Analysis,Size,Share,Growth,
Trends and Forecast, 2013 - 2019
Corporate
User License:
US $ 10795
Multi User
License: US $
7795
Single User
License: US $
4795
Buy Now
Request Sample
81
Pages
Report
Published Date : Jan
2014
3. Transparency Market Research has announced the publication of its latest report
“Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and
Oncology Applications) - Global Industry Analysis, Size, Share, Growth, Trends and
Forecast, 2013 – 2019”.
A new market research report by Transparency Market research sheds light on the growing
scope of the Nanomedicine Market globally, and provides an in-depth analysis of the
potential growth areas, restraints, region-wise revenue share, and much more.
The new title on “Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory,
Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share, Growth,
Trends and Forecast, 2013 - 2019," predicts that the total nanomedicine market globally will
be worth USD 177.60 billion by 2019, growing considerably from its 2012 value of USD
78.54 billion. This market is expected to achieve a compounded annual growth rate of
12.3% between 2013 and 2019.
The report talks about the major growth areas of within the nanomedicine market over the
period of forecast. The introduction of new technologies and applications in this sector will
propel growth to a significant degree at the global level. Further, the initiatives taken by
various governments as well as privately-funded institutions towards promoting the
commercialization of new nanomedicine products will boost this market. The report also
dwells on the role played by the rising geriatric population base, the prevalence of medical
needs that are in need of treatment, as well as the rising incidence of chronic diseases
globally.
PR : Nanomedicine Market is Expected to Reach USD 177.60
Billion Globally in 2019: Transparency Market Research
4. According to the report, the leading application segment within the nanomedicine market
was that of oncology, holding a 38% share of the overall market in 2012, as a vast number
of commercially available products prevail in this sector.
Browse the full report with complete TOC at
http://www.transparencymarketresearch.com/nanomedicine-market.html
The development of nanomedicine-based treatments and products that are able to directly
target tumors in the brain and other bodily sites is poised to be a significant factor affecting
growth in this market.
Though the largest market segment within the nanomedicine market is that of oncology, the
fastest growing segment is the cardiovascular market. According to the Transparency
Market Research report, growth in this segment has been fuelled by the presence of a
sizeable patient population, and a simultaneous growth in the demand for device and drugs
that are based on nanomedicine. These factors are collectively anticipated to further fuel the
growth of the cardiovascular segment within the nanomedicine market.
The report also carries out an in-depth analysis of the regional market share based on the
applications, revenue, and products. According to the report, the nanomedicine market was
largely dominated by North America in 2012. It is expected that this regional market will
continue to hold its leading position in the way over the forecast period until 2019.
Though the larger market share will be held by North America, it is anticipated that the
fastest growing market, by region, will be Asia-Pacific. The report states that the CAGR
recorded by the Asia-Pacific market will be 14.6% between 2013 and 2019.
Furthermore, the analysis of the regional markets also concludes that the Europe region is
predicted to show a growth rate that’s relatively higher than that of North America. Factors
that are likely to cause this increased growth rate include: an improvement in the
regulatory framework as well as the presence of a wide-ranging product portfolio in the
pipeline, set to be introduced by leading market players.
5. The report on the global nanomedicine market additionally comprises an overview of the
key market players in a section dedicated to company profiles. These key market players
include names such as: Abbott Laboratories, Merck & Co Inc, Pfizer Inc., GE Healthcare,
Nanosphere Inc., and many more.
To browse through the entire ToC or to purchase the report titled “Nanomedicine Market
(Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) -
Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”.
Browse the full report with complete TOC at
http://www.transparencymarketresearch.com/nanomedicine-market.html
The global nanomedicine market is categorized into the following segments:
Nanomedicine Market by Application
Neurology
Cardiovascular
Anti-Inflammatory
Anti-Infectives
Oncology
Others
Nanomedicine Market by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)
6. Chapter 1 Preface
1.1 Report description
1.2 Research Methodology
1.3 Market Segmentation
Chapter 2 Executive Summary
Related & Recently Published Reports by Transparency Market Research
Broadcast Switchers Market:
http://www.transparencymarketresearch.com/broadcast-switchers-
market.html
Refrigerated Display Cases (Plug-in and Remote) Market:
http://www.transparencymarketresearch.com/refrigerated-display-
cabinets.html
Physical Security (Hardware, Software and Services) Market:
http://www.transparencymarketresearch.com/physical-security-
market.html
Anti-aging Market: http://www.transparencymarketresearch.com/anti-
aging-market.html
Teleradiology Market:
http://www.transparencymarketresearch.com/teleradiology-technology-
Market.html
Molded Plastics Market:
http://www.transparencymarketresearch.com/molded-plastics-
market.html
Table of
Content
7. Chapter 3 Global Nanomedicine Market Overview
3.1 Market Dynamics
3.1.1 Market Drivers
3.1.1.1 Improvement in technology for nanomedicine
3.1.1.2 Rising government support for research and development in
nanomedicine
3.1.1.3 Presence of high unmet medical needs
3.1.1.4 Increase in investment amount and healthcare collaborations
3.1.1.5 High prevalence of chronic diseases
3.1.1.6 Impact Analysis of the Market Drivers
3.1.2 Market Restraints
3.1.2.1 Lack of organized regulatory framework
3.1.2.2 High costs involved
3.1.2.3 Impact Analysis of the Market Restraints
3.1.3 Market Opportunities
3.1.3.1 Presence of unmet medical needs in emerging economies
3.1.3.2 Identification of new medical applications
3.2 Porter’s Five Forces Analysis: Global Nanomedicine Market
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New entrants
3.2.4 Threat of Substitutes
3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis of the Global Nanomedicine Market, by Application
3.4 Global Nanomedicine Market, 2011 – 2019 (USD Million)
8. Chapter 4 Global Nanomedicine Market, by Applications
4.1 Overview
4.2 Nanomedicine for Neurology
4.2.1 Global Nanomedicine for Neurology Market, 2011 – 2019 (USD Billion)
4.3 Nanomedicine for Cardiovascular (CVS)
4.3.1 Global Nanomedicine for Cardiovascular Market , 2011 – 2019 (USD Billion)
4.4 Nanomedicine for Oncology
4.4.1 Global Nanomedicine for Oncology Market , 2011 – 2019 (USD Billion)
4.5 Nanomedicine for Anti-inflammatory
4.5.1 Global Nanomedicine for Anti-Inflammatory Market, 2011 – 2019 (USD Billion)
4.6 Nanomedicine for Anti-infectives
4.6.1 Global Nanomedicine for Anti-Infectives Market, 2011 – 2019 (USD Billion)
4.7 Other Applications
4.7.1 Global Nanomedicine Market for Other Applications, 2011 – 2019 (USD Billion)
4.8 Comparative Analysis: Global Nanomedicine Market by Applications, 2012 & 2019 (%)
Chapter 5 Global Nanomedicine Market, by Geography
5.1 Overview
5.1.1 Comparative Analysis of the Global Nanomedicine Market, by Geography, 2012 &
2019 (%)
5.2 North America
5.2.1 North America Nanomedicine Market, 2011 - 2019 (USD Billion)
5.3 Europe
5.3.1 Europe Nanomedicine Market, 2011 - 2019 (USD Billion)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Nanomedicine Market, 2011 - 2019 (USD Billion)
9. 5.5 Rest of the World
5.5.1 Rest of the World Nanomedicine Market, 2011 - 2019 (USD Billion)
Chapter 6 Recommendations
6.1 Collaborating with educational institutions to boost interdisciplinary education and
training
6.2 Identifying and prioritizing key growth areas
Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategies
7.1.5 Recent Developments
7.2 CombiMatrix Corporation
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategy
7.2.5 Recent Developments
7.3 Celgene Corporation
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Product Portfolio
10. 7.3.4 Business Strategies
7.3.5 Recent Developments
7.4 Mallinckrodt plc.
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategies
7.4.5 Recent Developments
7.5 GE Healthcare
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Product Portfolio
7.5.4 Business Strategies
7.5.5 Recent Developments
7.6 Johnson & Johnson
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Product Portfolio
7.6.4 Business Strategies
7.6.5 Recent Developments
7.7 Merck & Company Inc.
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Product Portfolio
7.7.4 Business Strategies
7.7.5 Recent Developments
11. 7.8 Nanosphere, Inc.
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Product Portfolio
7.8.4 Business Strategies
7.8.5 Recent Developments
7.9 Pfizer Inc.
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Product Portfolio
7.9.4 Business Strategies
7.10 Sigma-Tau Pharmaceuticals Inc.
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Product Portfolio
7.10.4 Business Strategies
7.10.5 Recent Developments
7.11 Teva Pharmaceutical Industries Ltd.
7.11.1 Company Overview
7.11.2 Financial Overview
7.11.3 Product Portfolio
7.11.4 Business Strategy
7.11.5 Recent Developments
7.12 UCB SA
7.12.1 Company Overview
7.12.2 Financial Overview
12. 7.12.3 Product Portfolio
7.12.4 Business Strategies
7.12.5 Recent Developments
Transparency Market Research is a global market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative forecasting
and trends analysis provides forward-looking insight for thousands of decision makers. We
are privileged with highly experienced team of Analysts, Researchers, and Consultants, who
use proprietary data sources and various tools and techniques to gather, and analyze
information.
Our data repository is continuously updated and revised by a team of research experts, so
that it always reflects the latest trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary and secondary research
techniques in developing distinctive data sets and research material for business reports.
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/
Blog: http://tmrmarketreport.blogspot.com/
Browse all Medical Devices Market Research Reports @
http://www.transparencymarketresearch.com/medical-devices-market-reports-
6.html
About Us
Contact us :